IL31 and myeloproliferative disorder: Notably, an increasing body of literature links IL-31 with malignant diseases such as endometrial carcinoma, lung cancer, myeloproliferative disorders, mastocytosis, cutaneous T cell lymphoma and follicular B cell lymphoma (7, 69, 71–76).